Navigation Links
Istituto Italiano di Tecnologia (IIT) and Movendo Technology Launch the Production of their First 30 Rehabilitative Hunova Robots
Date:5/23/2017

GENOA, Italy, May 23, 2017 /PRNewswire/ -- Hunova, the first robotic gym for the rehabilitation and functional motor sense evaluation of lower limbs and trunk, has been officially launched in Genoa, Italy. The first 30 robots will be available from June in Europe and the USA. The technology was developed and patented at the IIT laboratories and has been launched on the market by the IIT spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè.

To view the Multimedia News Release, please click:

Hunova_rehabilitative_robot
Hunova_rehabilitative_robot
Istituto Italiano di Tecnologia and Movendo Technology launch Hunova, the first rehabilitative robot
Istituto Italiano di Tecnologia and Movendo Technology launch Hunova, the first rehabilitative robot
Istituto_Italiano_di_Tecnologia
Istituto_Italiano_di_Tecnologia

https://www.multivu.com/players/uk/8108951-iit-movendo-launch-robot-hunova/

Hunova is a programmable robotic medical device that allows professionals in the geriatrics, neurology and sport rehabilitation field to cure and predict many neurological and orthopedic conditions. There are two main competitive advantages of this technology: Hunova is able to collect a significant amount of data on biomechanics, constantly monitoring the patient's progress. Secondly, it provides direct support to the patient through a guiding robotic system, offering a wide range of rehabilitation protocols in the form of video games. It consists of two electromechanical platforms equipped with sensors, characterized by two degrees of freedom (feet and seat level). The device integrates force sensors to adjust the interaction with the patient and a wireless sensor, which is placed on the patient's trunk, allowing the physiotherapist to check the movement of the torso.

Movendo Technology is an industry 4.0 that integrates cloud computing, big data analysis, robotics and artificial intelligence. Hunova's technologies are covered by international patents granted in concession from IIT, and it has already received CE certification for Europe and FDA certification in the US. So far, over 400 patients have been involved in clinical trials, resulting in the development of 156 customizable procedures both for prevention and rehabilitation treatments.

The first lot of devices will be delivered in June to European and US Hospitals and Physiotherapy Centres that have pre-ordered the new, unique, rehabilitative device. Movendo have already sold 10 robots (about 100K euros each). The Korian group, one of the leading companies in the European senior care sector, is among the main buyers with five Hunova robots purchased.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/istituto-italiano-di-tecnologia-iit-and-movendo-technology-launch-the-production-of-their-first-30-rehabilitative-hunova-robots-300461817.html


'/>"/>
SOURCE Istituto Italiano di Tecnologia (IIT)
Copyright©2017 PR Newswire.
All rights reserved


Related biology news :

1. Technology transforms health care
2. Geosphere features top geoscience technology, including LiDAR, EarthScope, CHIRP, ALSM, and IODP
3. Governor Corbett Presented 2013 Biotechnology Industry Organization Governor of the Year Award
4. 2013 AAPS National Biotechnology Conference returns to San Diego
5. Monoclonal Antibody with Xencors High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia
6. Gesture Recognition & Touchless Sensing Market (2013 - 2018): By Technology, Product, Application and Geography
7. AAPS announces 2013 National Biotechnology Conference award winners
8. New ACS journal Environmental Science and Technology Letters to rapidly publish urgent research
9. Ophthalmologist Inventors of Human Identification Technology Inducted into National Inventors Hall of Fame
10. Wexford Science & Technology Makes $150 Million Investment in Wake Forest Innovation Quarter
11. Intermountain Medical Center reseachers develop new 3-D technology to treat atrial fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Ill. , Oct. 4, 2017  GCE Solutions, a global ... new data and document anonymization solution on October 4, 2017. Shadow ... pharmaceutical field to comply with policy 0070 of the European Medicines ... and data. ... by GCE Solutions ...
(Date:7/20/2017)... DAL ) customers now can use fingerprints instead of their ... (DCA). ... launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May at ... process to allow eligible Delta SkyMiles Members who are enrolled in CLEAR ...
(Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik Family Foundation ... six Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. Established ... administered by the New York Academy of Sciences to honor the excellence of ...
(Date:10/12/2017)... San Diego, CA (PRWEB) , ... ... ... BioInformatics (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform ... eliminating all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology: